Navigation Links
Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
Date:3/23/2009

Randomized, Controlled, Multicenter Trial Will Test Ability of Adecatumumab to Prolong Disease Free Survival in High Risk Patients with Liver Metastases

BETHESDA, Md., March 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the commencement of a randomized, controlled phase 2 trial of its human anti-EpCAM IgG1 antibody adecatumumab (MT201) for the treatment of patients with colorectal cancer (CRC) after complete resection of liver metastases. The trial has three arms comparing single agent adecatumumab to combination chemotherapy (FOLFOX: 5-FU/Leucovorin plus Oxaliplatin), and to FOLFOX followed by adecatumumab. The primary endpoint will be the disease-free survival rate at one year.

"The relapse of colorectal cancer patients with liver metastases still represents an area with very high medical need" said the trial's principle investigator, Professor Peter Neuhaus, from the Charite University Hospital in Berlin, Germany. "Recent intensification of chemotherapeutic regimens has shown only modest benefit and there is significant room for improvement in these patients. EpCAM is a cancer target which is highly expressed in colorectal cancer, and targeted therapies such as adecatumumab could become a major breakthrough in this setting if proven successful."

Apart from being the most highly and frequently expressed target antigen on colorectal cancer cells, EpCAM has recently been shown to drive tumor growth and to be expressed on colorectal cancer stem cells (1). The ability of adecatumumab to potentially control and eliminate newly developing metastases has been suggested in a recently reported Phase 2 trial of adecatumumab as monotherapy in metastatic
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Micromet Key Events for 2009
2. Micromet Expands Committed Equity Financing Facility to $75 Million
3. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
4. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
5. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
6. Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results
7. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
8. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
11. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... today lauded the latest results achieved by the ... known as the National Precursor Log Exchange (NPLEx), ... enforcement officials track down methamphetamine offenders and make ... in Michigan blocked the ...
(Date:8/20/2014)... YORK , Aug. 20, 2014 ... is available in its catalogue: The ... IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Act" (H.R. 3590) is complex legislation that affects ... of its provisions are beginning to take effect ...
(Date:8/20/2014)... , Aug. 20, 2014 Torrance ... be using advanced, ventilator technology from Covidien to ... care for patients. The acute ... naturally, compared to conventional mechanical ventilation, and help ... as possible. Patients on mechanical ventilation are often ...
Breaking Medicine Technology:Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2
(Date:8/21/2014)... 2014 mynt welcomes industry leaders Rob ... join its growing company. Since its pre-launch in April, ... sales and continues to gain momentum leading up to ... and Tiffanie came into network marketing by chance. Tiffanie ... of network marketing companies. Tiffanie needed help at one ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According ... by Application (Biodegradable polymer, Food & Beverage, Personal ... Application (Packaging, Agriculture, Automobile, Electronics, Textile) & Geography ... the lactic acid and polylactic acid markets and ... of each market, based on their sub-segments, in ...
(Date:8/21/2014)... San Luis Obispo, CA (PRWEB) August 21, 2014 ... July/August edition of Current Pedorthics, a bi-monthly publication of the ... the field of pedorthics. , Bunion Bootie ... as an alternative solution for bunion sufferers and their pain. ... be worn in nearly any shoe to eliminate the friction ...
(Date:8/21/2014)... 2014 While golfing in Scotland and ... to stay focused on his game due to the ... whine, slapping and continual need to spray insect repellent ... stay protected from insects while golfing. He ultimately found ... Financial Services/Investment Banking Industry, decided to change direction and ...
(Date:8/21/2014)... August 21, 2014 Atlantic Information Services, ... ACO Business News and The AIS Report on Blue ... Blue Cross Blue Shield Association or its member companies) ... latest report in AIS’s Management Insight Series. Bundled ... studies of two insurers — Horizon Healthcare Services, Inc. ...
Breaking Medicine News(10 mins):Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2
... , - Tobacco use is the single most preventable cause of death ... 400,000 Americans die each year from tobacco-related disease , ... , illegal drugs, car crashes, fires, murders, and suicides combined. ... seconds . , , HOUSTON, June 23 DaretoQuit.com is ...
... earlier this month by Harvard Law School, Harvard Medical ... bills are involved in more than 60 percent of US ... more than 75 percent of these families reported having health ... wake of these startling increases and the current recession, The ...
... At Risk with Atlantic Hurricane Predictions; Are Their Medical Records ... With hurricane season upon us, more than 35 million Americans ... their medical records. According to the National Ocean and ... having nine to 14 named storms, of which four to ...
... ... provides up to 99% accuracy right out of the box. The Nuance Dragon Medical 10.1 ... the ideal chance for existing Dragon Medical users to upgrade and become even more efficient. ... Austin, Texas (PRWEB) June ...
... June 23 /PRNewswire-Asia/ -- Wan (Corporate Services) Ltd., the,sole agent of Perrier ... level of Perrier. , ... We strongly believe the Consumer Council Findings is not correct. ... mg/L of Nitrite in Perrier is,not correct. , ...
... tumor growth , MONDAY, June 22 (HealthDay News) -- A ... of cancer and could potentially be harnessed as a cancer ... for inhibiting or treating metastasis -- the migration of cancer ... the body. Metastasis is one of the leading causes of ...
Cached Medicine News:Health News:STOP SMOKING ONLINE: Houston Psychologists Develop Groundbreaking, Interactive Stop Smoking Program 2Health News:The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 2Health News:The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 3Health News:Consumers Encouraged to Add Personal Health Records (PHR) to Hurricane Preparedness Checklist 2Health News:Consumers Encouraged to Add Personal Health Records (PHR) to Hurricane Preparedness Checklist 3Health News:The New Dragon Medical 10.1 is Now Available 2Health News:The New Dragon Medical 10.1 is Now Available 3Health News:Perrier Clarifies the NITRITE Level in Consumer Council Findings 2Health News:Lab Study Finds Protein That May Inhibit Cancer Spread 2
... the parafollicular C-cells of the thyroid gland ... major action of calcitonin is to lower ... resulting in decreased mobilization of calcium from ... in conditions associated with high levels of ...
Validated by decades of research and clinical experience, HFA is the accepted standard of care in glaucoma diagnosis and management. With HFA you can feel confident you're providing the best possible...
Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery...
... The Bio-Optics LSM-12000 is a new High ... new tool in anterior segment diagnostics and ... to operate, easy to maintain, and very ... the only High Magnification Slit-Lamp Biomicroscope available ...
Medicine Products: